Posters Overview
The success of GLP-1 receptor agonists has transformed metabolic disease therapy and accelerated peptide drug development across multiple fields. However, applying fatty acid-modified GLP-1 design principles to next-generation candidates often requires more sophisticated preclinical approaches.

Complete the form to view and download this poster.
Stay Connected
Keep up with the latest news and insights.